Tiagabine Protects Dopaminergic Neurons against Neurotoxins by Inhibiting Microglial Activation

[1]  D. Cai,et al.  Hypothalamic Programming of Systemic Aging Involving IKKβ/NF-κB and GnRH , 2013, Nature.

[2]  D. Liebetanz,et al.  Pegylated granulocyte colony-stimulating factor conveys long-term neuroprotection and improves functional outcome in a model of Parkinson's disease. , 2012, Brain : a journal of neurology.

[3]  S. Pluchino,et al.  Plasticity of Subventricular Zone Neuroprogenitors in MPTP (1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine) Mouse Model of Parkinson's Disease Involves Cross Talk between Inflammatory and Wnt/β-Catenin Signaling Pathways: Functional Consequences for Neuroprotection and Repair , 2012, The Journal of Neuroscience.

[4]  Y. Pak,et al.  Ethyl Pyruvate Rescues Nigrostriatal Dopaminergic Neurons by Regulating Glial Activation in a Mouse Model of Parkinson’s Disease , 2011, The Journal of Immunology.

[5]  E. Kavanagh,et al.  Caspase signalling controls microglia activation and neurotoxicity , 2011, Nature.

[6]  C. Bouzat,et al.  An intrinsic GABAergic system in human lymphocytes , 2011, Neuropharmacology.

[7]  W. Wong,et al.  Microglial Morphology and Dynamic Behavior Is Regulated by Ionotropic Glutamatergic and GABAergic Neurotransmission , 2011, PloS one.

[8]  P. Mcgeer,et al.  Astrocytes are GABAergic cells that modulate microglial activity , 2011, Glia.

[9]  B. Jin,et al.  Paroxetine Prevents Loss of Nigrostriatal Dopaminergic Neurons by Inhibiting Brain Inflammation and Oxidative Stress in an Experimental Model of Parkinson’s Disease , 2010, The Journal of Immunology.

[10]  K. Nordlind,et al.  GABA and GABAA receptor expression on immune cells in psoriasis: a pathophysiological role , 2010, Archives of Dermatological Research.

[11]  Fred H. Gage,et al.  Mechanisms Underlying Inflammation in Neurodegeneration , 2010, Cell.

[12]  Melissa Miranda,et al.  Inhibitory role for GABA in autoimmune inflammation , 2010, Proceedings of the National Academy of Sciences.

[13]  J. Fei,et al.  γ-Aminobutyric Acid Transporter 1 Negatively Regulates T Cell Activation and Survival through Protein Kinase C-Dependent Signaling Pathways1 , 2009, The Journal of Immunology.

[14]  R. Hays,et al.  SF-36 includes less Parkinson Disease (PD)-targeted content but is more responsive to change than two PD-targeted health-related quality of life measures , 2009, Quality of Life Research.

[15]  M. Oh,et al.  Neuroprotective Effect of Ghrelin in the 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine Mouse Model of Parkinson’s Disease by Blocking Microglial Activation , 2009, Neurotoxicity Research.

[16]  Y. Xu,et al.  γ-Aminobutyric acid transpoter 1 negatively regulates T cell-mediated immune responses and ameliorates autoimmune inflammation in the CNS , 2009, The Journal of Immunology.

[17]  Shuting Lin,et al.  γ-Aminobutyric Acid Transporter 1 Negatively Regulates T Cell-Mediated Immune Responses and Ameliorates Autoimmune Inflammation in the CNS1 , 2008, The Journal of Immunology.

[18]  J. Trojanowski,et al.  Neuroinflammation and Oxidation/Nitration of α-Synuclein Linked to Dopaminergic Neurodegeneration , 2008, The Journal of Neuroscience.

[19]  F. Sun,et al.  Expression of Cbl-interacting protein of 85 kDa in MPTP mouse model of Parkinson's disease and 1-methyl-4-phenyl-pyridinium ion-treated dopaminergic SH-SY5Y cells. , 2008, Acta biochimica et biophysica Sinica.

[20]  Jing Xu,et al.  Additive neuroprotection of GABA A and GABA B receptor agonists in cerebral ischemic injury via PI-3K/Akt pathway inhibiting the ASK1-JNK cascade , 2008, Neuropharmacology.

[21]  C. Ross,et al.  Tiagabine is neuroprotective in the N171-82Q and R6/2 mouse models of Huntington's disease , 2008, Neurobiology of Disease.

[22]  F. Cicchetti,et al.  Beneficial effects of dietary omega‐3 polyunsaturated fatty acid on toxin‐induced neuronal degeneration in an animal model of Parkinson's disease , 2008, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[23]  F. Hernández-hernández,et al.  GABA (A) receptor subunits RNA expression in mice peritoneal macrophages modulate their IL-6/IL-12 production , 2007, Journal of Neuroimmunology.

[24]  G. Bing,et al.  Inflammation induces mitochondrial dysfunction and dopaminergic neurodegeneration in the nigrostriatal system , 2007, Journal of neurochemistry.

[25]  S. Przedborski,et al.  Protocol for the MPTP mouse model of Parkinson's disease , 2007, Nature Protocols.

[26]  I. Han,et al.  IL‐1β, an immediate early protein secreted by activated microglia, induces iNOS/NO in C6 astrocytoma cells through p38 MAPK and NF‐κB pathways , 2006 .

[27]  D. Cui,et al.  Mice with genetically altered GABA transporter subtype I (GAT1) expression show altered behavioral responses to ethanol , 2006, Journal of neuroscience research.

[28]  Hanwei Zhang,et al.  γ-Aminobutyric Acid Inhibits T Cell Autoimmunity and the Development of Inflammatory Responses in a Mouse Type 1 Diabetes Model1 , 2004, The Journal of Immunology.

[29]  P. Mcgeer,et al.  Inflammation and neurodegeneration in Parkinson's disease. , 2004, Parkinsonism & related disorders.

[30]  H. Kettenmann,et al.  Microglia express GABAB receptors to modulate interleukin release , 2004, Molecular and Cellular Neuroscience.

[31]  M. Vila,et al.  D-beta-hydroxybutyrate rescues mitochondrial respiration and mitigates features of Parkinson disease. , 2003, The Journal of clinical investigation.

[32]  B. Volpe,et al.  Age-related microglial activation in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced dopaminergic neurodegeneration in C57BL/6 mice , 2003, Brain Research.

[33]  J. Cano,et al.  Lipopolysaccharide Intranigral Injection Induces Inflammatory Reaction and Damage in Nigrostriatal Dopaminergic System , 1998, Journal of neurochemistry.

[34]  I. Han,et al.  IL-1beta, an immediate early protein secreted by activated microglia, induces iNOS/NO in C6 astrocytoma cells through p38 MAPK and NF-kappaB pathways. , 2006, Journal of neuroscience research.